Shanghai No1 Pharmacy Co Ltd
Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. It sells food, medical equipment, health convenience products, and other commodities. The company serves terminal medical institutions, pharmacies, commodity distribution companies, and company franchise stores companies. Shanghai No. 1 Pharmacy Co.,Ltd. was fo… Read more
Shanghai No1 Pharmacy Co Ltd (600833) - Total Liabilities
Latest total liabilities as of June 2025: CN¥893.93 Million CNY
Based on the latest financial reports, Shanghai No1 Pharmacy Co Ltd (600833) has total liabilities worth CN¥893.93 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shanghai No1 Pharmacy Co Ltd - Total Liabilities Trend (1994–2024)
This chart illustrates how Shanghai No1 Pharmacy Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shanghai No1 Pharmacy Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shanghai No1 Pharmacy Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hamilton Thorne Ltd
PINK:HTLZF
|
USA | $43.40 Million |
|
Neo Performance Materials Inc
PINK:NOPMF
|
USA | $248.37 Million |
|
ButOne Information Corp XiAn
SHG:600455
|
China | CN¥979.08 Million |
|
Graf Global Corp
NYSE MKT:GRAF
|
USA | $10.60 Million |
|
ODAS Elektrik Uretim Sanayi Ticaret AS
IS:ODAS
|
Turkey | TL6.89 Billion |
|
Talgo SA
MC:TLGO
|
Spain | €1.28 Billion |
|
Shandong Gold Phoenix Co Ltd
SHG:603586
|
China | CN¥372.76 Million |
Liability Composition Analysis (1994–2024)
This chart breaks down Shanghai No1 Pharmacy Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai No1 Pharmacy Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai No1 Pharmacy Co Ltd (1994–2024)
The table below shows the annual total liabilities of Shanghai No1 Pharmacy Co Ltd from 1994 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥835.66 Million | -2.23% |
| 2023-12-31 | CN¥854.72 Million | -20.89% |
| 2022-12-31 | CN¥1.08 Billion | +94.13% |
| 2021-12-31 | CN¥556.54 Million | -13.97% |
| 2020-12-31 | CN¥646.94 Million | +33.61% |
| 2019-12-31 | CN¥484.21 Million | +18.13% |
| 2018-12-31 | CN¥409.90 Million | -2.85% |
| 2017-12-31 | CN¥421.90 Million | -6.10% |
| 2016-12-31 | CN¥449.29 Million | +0.50% |
| 2015-12-31 | CN¥447.04 Million | +3.96% |
| 2014-12-31 | CN¥430.01 Million | +13.15% |
| 2013-12-31 | CN¥380.03 Million | -3.16% |
| 2012-12-31 | CN¥392.43 Million | +7.57% |
| 2011-12-31 | CN¥364.80 Million | +3.55% |
| 2010-12-31 | CN¥352.30 Million | +10.33% |
| 2009-12-31 | CN¥319.32 Million | +16.14% |
| 2008-12-31 | CN¥274.95 Million | -9.26% |
| 2007-12-31 | CN¥303.03 Million | +28.74% |
| 2006-12-31 | CN¥235.38 Million | +112.08% |
| 2005-12-31 | CN¥110.98 Million | -50.98% |
| 2004-12-31 | CN¥226.40 Million | -23.41% |
| 2003-12-31 | CN¥295.59 Million | -2.15% |
| 2002-12-31 | CN¥302.08 Million | -4.78% |
| 2001-12-31 | CN¥317.24 Million | -63.93% |
| 2000-12-31 | CN¥879.40 Million | -14.12% |
| 1999-12-31 | CN¥1.02 Billion | +15.46% |
| 1998-12-31 | CN¥886.85 Million | +6.81% |
| 1997-12-31 | CN¥830.27 Million | -23.07% |
| 1996-12-31 | CN¥1.08 Billion | +16.10% |
| 1995-12-31 | CN¥929.63 Million | +73.09% |
| 1994-12-31 | CN¥537.09 Million | -- |